In this study, we collected 340 UUTS patients who received one-stage FURL, of which 31 patients (9.12%) developed SIRS. Previous study reported the incidence of SIRS during and after FURL was 6.7–20.7% [6]. Sepsis is the most serious complication of FURL, which can lead to septic shock and even death [7]. Levy et al. gathered statistic on 25375 sepsis patients, including 18766 in the United States and 6609 in Europe, with adjusted mortality rates of 32.3% and 31.3%, respectively [8].
Patients who received one-stage FULR had a higher risk of developing SIRS compared to those who received two-stages FULR [3]. Thus, it is important for urologists to manage the risk of SIRS in FURL through general preoperative examinations and convenient tools.
In this study, we chose SIRS as an indicator to reflect urinary tract infections in UUTS patients. SIRS is a widely recognized marker of systemic inflammation and is considered to be an early manifestation of sepsis [9–11]. Some scholars had used other methods to predict sepsis early, such as quick sequential organ failure assessment (qSOFA) predicting sepsis based on changes in respiratory rate, systolic blood pressure, and mental state, but its effectiveness was not satisfactory [12–13]. Norwegian scholars conducted a statistical analysis of 1535 infected patients, of which 108 patients had sepsis, but only 33 (30.1%) met the qSOFA criteria, and among the 26 patients who died within 7 days, only 4 (15.4%) had a qSOFA score > = 2 [12]. Some other diseases may cause false positive of qSOFA, such as cardiac embolism, respiratory distress syndrome, severe trauma, anaphylactic shock. Due to the low sensitivity of qSOFA to sepsis, the international sepsis and septic shock management guidelines strongly recommend not using it as a single screening tool, and pointed out that SIRS judges sepsis levels higher than qSOFA, blood lactate, and other indicators [13].
The variables in our study were based on routine preoperative examinations of patients with UUTS, and the result showed that age, urinary WBC, urine bacterial culture and SII value were the independent risk factor for SIRS. Compared with young UUTS patients, elderly patients have lower immune function and more potential diseases, which may lead to a higher risk of developing SIRS. In our study, using urine WBC 3 + predicted SIRS with a sensitivity of 0.53 and a specificity of 0.95, and the sensitivity and specificity of SIRS predicted using urine bacterial culture were 0.63 and 0.94, respectively. Previous studies based on multiple logistic regression analysis had found that urine WBC positivity, urine bacterial culture positivity, and urine nitrite positivity were independent risk factors for inducing fever and SIRS in patients with UUTC [1, 14]. Nitrite is usually not present in normal urine. Bacteria in urine, especially gram negative bacteria, can convert nitrate into nitrite. However, only 6 patients with urinary nitrite positive patients were included in this study, resulting in urinary nitrite not being included in the analysis. Our results showed that SII had the highest OR (30.356) for developing SIRS in UUTS patients undergoing one-stage FURL. The sensitivity and specificity of predicting SIRS using urine SII > 1300 were 0.59 and 0.98, respectively. SII had been proven to be a promising prognostic indicator for evaluating the development of various inflammatory diseases and the prognosis of various malignant tumors [15–18]. Preoperative SII had also been proven to be an important indicator for evaluating the risk of infection in patients undergoing various surgeries, such as knee arthroplasty, cardiac stent implantation, lung surgery, etc [19–21]. In the field of urological lithotripsy, Peng et al. investigated the value of preoperative SII in predicting SIRS in PCNL and found that SII had better predictive effect than traditional inflammatory predictors [22]. Infectious UUTS is more prone to SIRS response, and elevated neutrophils and decreased lymphocyte may secrete inflammatory mediators that may accelerate stone formation. Platelet activation can release vascular permeability factors by releasing 5-hydroxytryptamine from alpha particles and dense particles, enhancing vascular permeability, promoting chemotactic white blood cells, and participating in the inflammatory process [22]. However, we had not found any studies on preoperative SII predicting infection in the field of FURL.
Nomogram, a statistical tool that visualizes multiple independent risk factors, is is widely used to assess the risk of disease occurrence and prognosis [23–24]. Compared with the previous nomogram predicting SIRS risk for patients undergoing FURL [25–26], our nomogram model had the following differences. Firstly, the subjects of this study were all patients receiving one-stage FURL. The focus of this study was to evaluate the risk of SIRS in UUTS patients who without ureteral stents implanted before FURL, and to facilitate better selection of surgical methods in clinical practice. Second, we evaluated for the first time the effect of SII on the development of SIRS in patients undergoing one-stage FURL. Third, we had established a risk scoring system of developing SIRS in one-stage FURL for the first time and classified the risk into four grades. In our risk scoring system, SII > 1300 had the highest score of 47. Our risk scoring system showed grade IV with points 55 to 100, and the risk multiple for developing SIRS in grade IV was 9.077 compared with the general population. We strongly recommend that UUTC patients with a preoperative score of grade four should undergo two-stage FURL. In addition, we strongly recommend that a ureteral stent should be placed before FURL in patients with SII greater than 1300 and one of the following: age>60 years, urinary white blood cell 1+/2+/3+, or Urine bacterial culture positive.
However, there are still some limitations in our study. First, the limitation on the number of patients may introduce bias into our results. Second, some variables, such as gender, diabetes, stone size, ureteral access sheath and surgery time, had no statistical significance in this study, but had been confirmed to have an impact on SIRS risk in other studies [6, 27–28]. Finally, this study is a retrospective analysis of a single medical institution and requires further prospective studies and external validation to validate our results.